| Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 T Vandamme, M Peeters, F Dogan, P Pauwels, E Van Assche, M Beyens, ... Journal of molecular endocrinology 54 (2), 137-147, 2015 | 108 | 2015 |
| Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer L Croes, M Beyens, E Fransen, J Ibrahim, W Vanden Berghe, A Suls, ... Clinical epigenetics 10, 1-13, 2018 | 93 | 2018 |
| Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors T Vandamme, M Beyens, KO de Beeck, F Dogan, PM van Koetsveld, ... British journal of cancer 114 (6), 650-658, 2016 | 87 | 2016 |
| Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung Z Vermeulen, AS Hervent, L Dugaucquier, L Vandekerckhove, ... American Journal of Physiology-Heart and Circulatory Physiology 313 (5 …, 2017 | 79 | 2017 |
| Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer J Ibrahim, K Op de Beeck, E Fransen, L Croes, M Beyens, A Suls, ... Cancer medicine 8 (5), 2133-2145, 2019 | 55 | 2019 |
| Mutation and methylation analysis of circulating tumor DNA can be used for follow-up of metastatic colorectal cancer patients N Boeckx, KO de Beeck, M Beyens, V Deschoolmeester, C Hermans, ... Clinical colorectal cancer 17 (2), e369-e379, 2018 | 40 | 2018 |
| Cell-free DNA from metastatic pancreatic neuroendocrine tumor patients contains tumor-specific mutations and copy number variations G Boons, T Vandamme, M Peeters, M Beyens, A Driessen, K Janssens, ... Frontiers in oncology 8, 467, 2018 | 35 | 2018 |
| Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors M Beyens, T Vandamme, M Peeters, G Van Camp, KO de Beeck Endocrine-related cancer 26 (3), R109-R130, 2019 | 34 | 2019 |
| Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms T Vandamme, M Beyens, G Boons, A Schepers, K Kamp, K Biermann, ... Endocrine-related cancer 26 (1), 1-12, 2019 | 29 | 2019 |
| Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma M Hylebos, G Van Camp, G Vandeweyer, E Fransen, M Beyens, ... Oncotarget 8 (69), 113673, 2017 | 23 | 2017 |
| Variants affecting diverse domains of MEPE are associated with two distinct bone disorders, a craniofacial bone defect and otosclerosis I Schrauwen, H Valgaeren, L Tomas-Roca, M Sommen, U Altunoglu, ... Genetics in Medicine 21 (5), 1199-1208, 2019 | 20 | 2019 |
| Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages T Vandamme, M Beyens, M Peeters, G Van Camp, KO de Beeck Cancer genetics 208 (10), 523, 2015 | 17 | 2015 |
| Insufficient evidence for a role of SERPINF1 in otosclerosis H Valgaeren, M Sommen, M Beyens, G Vandeweyer, I Schrauwen, ... Molecular Genetics and Genomics 294 (4), 1001-1006, 2019 | 12 | 2019 |
| pyAmpli: an amplicon-based variant filter pipeline for targeted resequencing data M Beyens, N Boeckx, G Van Camp, K Op de Beeck, G Vandeweyer BMC bioinformatics 18, 1-6, 2017 | 8 | 2017 |
| 568 Schrijvers DM, De Meyer GRY, Maudsley S, De Keulenaer GW, and Segers VFM Z Vermeulen, AS Hervent, L Dugaucquier, L Vandekerckhove, ... Inhibitory actions of 569, 0 | 6 | |
| Identification of resistance mechanisms for EGFR-targeted therapy in head and neck squamous cell carcinoma: Combining whole-exome sequencing and tumour kinase profiling I De Pauw, A Wouters, J Van den Bossche, KO de Beeck, M Beyens, ... Annals of Oncology 29, vi22, 2018 | 3 | 2018 |
| Altered DNA methylation in estrogen-responsive repetitive sequences of spermatozoa of infertile men with shortened anogenital distance L Stenz, M Beyens, ME Gill, A Paoloni-Giacobino, C De Geyter Clinical Epigenetics 14 (1), 185, 2022 | 1 | 2022 |
| Detection of mutations and copy number alterations in circulating DNA from pancreatic neuroendocrine tumor patients G Boons, KO de Beeck, T Vandamme, M Beyens, G Roeyen, K Janssens, ... Annals of Oncology 29, viii477, 2018 | 1 | 2018 |
| PO-367 DFNA5 methylation: a potential biomarker for breast cancer, on the basis of a large scale analysis in TCGA L Croes, M Beyens, E Fransen, J Ibrahim, WV Berghe, A Suls, M Peeters, ... ESMO Open 3, A165, 2018 | 1 | 2018 |
| Epigenomic analyses in sub-populations of spermatozoa from infertile men with short anogenital distance L Stenz, M Beyens, M Gill, C De Geyter, A Giacobino Abstracts/Toxicology Letters 350S 1, S276, 2021 | | 2021 |
Timon VandammeSenior consultant digestive and neuroendocrine oncology , University Hospital AntwerpVerified email at uantwerp.be
